Antimicrobial activity of brown alga eisenia bicyclis against methicillin-resistant staphylococcus aureus

Fisheries and Aquatic Sciences

Volumn 14, Issue 4, 2012, Pages 251-256

  Eom, Sung Hwan ^a   Park, Jae Hong ^a   Yu, Dae Ung ^a   Choi, Ji Il ^a   Choi, Jong Duck ^b   Lee, Myung Suk ^a   Kim, Young Mog ^a  

^a Pukyong National University   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

Anti MRSA activity; Eisenia bicyclis; Methicillin resistant staphylococcus aureus

Indexed keywords

EISENIA BICYCLIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PHAEOPHYCEAE; STAPHYLOCOCCUS AUREUS;

EID: 84930475401     PISSN: 12269204     EISSN: None     Source Type: Journal    
DOI: 10.5657/FAS.2011.0251     Document Type: Article

References (27)

1. Barna JCJ and Williams DH. 1984. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu Rev Microbiol 38, 339-357.
2. Bramley AJ, Patel AH, O'Reilly M, Foster R and Foster TJ. 1989. Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. Infect Immun 57, 2489-2494.
3. Choi JG, Kang OH, Brice OO, Lee YS, Chae HS, Oh YC, Sohn DH, Park H, Choi HG, Kim SG, Shin DW and Kwon DY. 2010. Antibacterial activity of Ecklonia cava against methicillin-resistant Staphylococcus aureus and Salmonella spp. Foodborne Pathog Dis 7, 435-441.
4. Eom SH, Kang YM, Park JH, Yu DU, Jeong ET, Lee MS and Kim YM. 2011. Enhancement of polyphenol content and antioxidant activity of Eisenia bicyclis extract by microbial fermentation. Fish Aquat Sci 14, 192-197.
5. Grierson DS and Afolayan AJ. 1999. Antibacterial activity of some indigenous plants used for the treatment of wounds in the Eastern Cape, South Africa. J Ethnopharmacol 66, 103-106.
6. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T and Tenover FC. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40, 135-136.
7. Isnansetyo A and Kamei Y. 2009. Anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of MC21-B, an antibacterial compound produced by the marine bacterium Pseudoalteromonas phenolica O-BC30T. Int J Antimicrob Agents 34, 131-135.
8. Isnansetyo A, Horikawa M, and Kamei Y. 2001. In vitro anti-methicillin-resistant Staphylococcus aureus activity of 2,4-diacetylphloroglucinol produced by Pseudomonas sp. AMSN isolated from a marine alga. J Antimicrob Chemother 47, 724-725.
9. Jung HA, Oh SH and Choi JS. 2010. Molecular docking studies of phlo rotannins from Eisenia bicyclis with BACE1 inhibitory activity. Bioorg Med Chem Lett 20, 3211-3215.
10. Kang K, Park Y, Hwang HJ, Kim SH, Lee JG and Shin HC. 2003. Antioxidative properties of brown algae polyphenolics and their perspectives as chemopreventive agent against vascular risk factors. Arch Pharm Res 26, 286-293.
11. Kaplan SL. 2005. Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients. Infect Dis Clin N Am 19, 747-757.
12. Kim JH, Lee DS, Lim CW, Park HY and Park JH. 2002. Antibacterial activity of sea-mustard, Laminaria japonica extracts on the cariogenic bacteria, Streptococcus mutans. J Korean Fish Soc 35, 191-195.
13. Kim SM, Shang YF and Um BH. 2011. A preparative method for isolation of fucoxanthin from Eisenia bicyclis by centrifugal partition chromatography. Phytochem Anal 22, 322-329.
14. Kim MM, Ta QV, Mendis E, Rajapakse N, Jung WK, Byun HG, Jeon YJ and Kim SK. 2006. Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity. Life Sci 79, 1436-1443.
15. Lee DS, Kang MS, Hwang HJ, Eom SH, Yang JY, Lee MS, Lee WJ, Jeon YJ, Choi JS and Kim YM 2008. Synergistic effect between dieckol from Ecklonia stolonifera and β-lactams against methicillin-resistant Staphylococcus aureus. Biotechnol Bioprocess Eng 13, 758-764.
16. Lin RD, Chin YP, Hou WC and Lee MH. 2008. The effects of antibiotics combined with natural polyphenols against clinical methicillin-resistant Staphylococcus aureus (MRSA). Planta Med 74, 840-846.
17. McDougall GJ, Shpiro F, Dobson P, Smith P, Blake A and Stewart D. 2005. Different polyphenolic components of soft fruits inhibit alpha-amylase and alpha-glucosidase. J Agric Food Chem 53, 2760-2766.
18. Nagayama K, Iwamura Y, Shibata T, Hirayama I and Nakamura T. 2002. Bactericidal activity of phlorotannins from the brown alga Ecklonia kurome. J Antimicrob Chemother 50, 889-893.
19. National Committee for Clinical Laboratory Standards (NCCLS). 2003. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard. 6th ed. NCCLS Document M7-A6. NCCLS, Wayne, PA, US.
20. National Committee for Clinical Laboratory Standards (NCCLS). 2004. Performance Standards for Antimicrobial Disk Susceptibility Testing. 14th Informational Supplement. NCCLS Document M100-514. NCCLS, Wayne, PA, US.
21. Noda H, Amano H, Arashima K, Hashimoto S and Nisizawa K. 1989. Studies on the antitumour activity of marine algae. Nippon Suisan Gakkaishi 55, 1259-1264.
22. Okada Y, Ishimaru A, Suzuki R and Okuyama T. 2004. A new phloroglucinol derivative from the brown alga Eisenia bicyclis: potential for the effective treatment of diabetic complications. J Nat Prod 67, 103-105.
23. Shen CC, Syu WJ, Li SY, Lin CH, Lee GH and Sun CM. 2002. Antimicrobial activities of Naphthazarins from Arnebia euchroma. J Nat Prod 65, 1857-1862.
24. Shibata T, Fujimoto K, Nagayama K, Yamaguchi K and Nakamura T. 2002. Inhibitory activity of brown algal phlorotannins against hyaluronidase. Int J Food Sci Technol 37, 703-709.
25. Shibata T, Nagayama K, Tanaka R, Yamaguchi K and Nakamura T. 2003. Inhibitory effects of brown algal phlorotannins on secretory phospholipase A2s, lipoxygenases and cyclooxygenases. J Appl Phycol 15, 61-66.
26. Syu WJ, Shen CC, Lu JJ, Lee GH Sun CM. 2004. Antimicrobial and cytotoxic activities of neolignans from Magnolia officinalis. Chem Biodivers 1, 530-537.
27. Totsuka K, Shiseki M, Kikuchi K and Matsui Y. 1999. Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo. J Antimicrob Chemother 44, 455-460.